FEATURED COMPANIES
- AB Enzymes
- Amicogen inc.
- Aumgene Biosciences
- Biocatalysts Ltd.
- Codexis inc.
- Koninklijke DSM N.V.
Specialty Enzymes Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global specialty enzymes market.
This report focuses on specialty enzymes market which is experiencing strong growth. The report gives a guide to the specialty enzymes market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Where is the largest and fastest growing market for the specialty enzymes market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Specialty Enzymes market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider specialty enzymes market, and compares it with other markets.
1) By Type: Carbohydrases; Proteases; Lipases; Polymerases & Nucleases; Oxidase & Hydratases; Others
2) By Source: Microorganisms; Animals; Plants
3) By Application: Pharmaceutical; Diagnostics; Research & Biotechnology; Food & Beverage; Animal Nutrition; Others
Companies Mentioned: BASF SE; Novozymes A/S; Roche Holding AG; Codexis Inc; Specialty Enzymes & Probiotics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
This report focuses on specialty enzymes market which is experiencing strong growth. The report gives a guide to the specialty enzymes market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the specialty enzymes market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Specialty Enzymes market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider specialty enzymes market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
- Market segmentations break down market into sub markets
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
- The specialty enzymes market section of the report gives context. It compares the specialty enzymes market with other segments of the specialty enzymes market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, specialty enzymes market indicators comparison
Scope
Markets Covered:
1) By Type: Carbohydrases; Proteases; Lipases; Polymerases & Nucleases; Oxidase & Hydratases; Others
2) By Source: Microorganisms; Animals; Plants
3) By Application: Pharmaceutical; Diagnostics; Research & Biotechnology; Food & Beverage; Animal Nutrition; Others
Companies Mentioned: BASF SE; Novozymes A/S; Roche Holding AG; Codexis Inc; Specialty Enzymes & Probiotics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Specialty Enzymes Market
What is the estimated value of the Global Specialty Enzymes Market?
What is the growth rate of the Global Specialty Enzymes Market?
What is the forecasted size of the Global Specialty Enzymes Market?
Who are the key companies in the Global Specialty Enzymes Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AB Enzymes
- Amicogen inc.
- Aumgene Biosciences
- Biocatalysts Ltd.
- Codexis inc.
- Koninklijke DSM N.V.
1. Executive Summary2. Specialty Enzymes Market Characteristics3. Specialty Enzymes Market Trends And Strategies4. Impact Of COVID-19 On Specialty Enzymes28. Specialty Enzymes Pipeline Analysis29. Key Mergers And Acquisitions In The Specialty Enzymes Market30. Specialty Enzymes Market Future Outlook and Potential Analysis
5. Specialty Enzymes Market Size And Growth
6. Specialty Enzymes Market Segmentation
7. Specialty Enzymes Market Regional And Country Analysis
8. Asia-Pacific Specialty Enzymes Market
9. China Specialty Enzymes Market
10. India Specialty Enzymes Market
11. Japan Specialty Enzymes Market
12. Australia Specialty Enzymes Market
13. Indonesia Specialty Enzymes Market
14. South Korea Specialty Enzymes Market
15. Western Europe Specialty Enzymes Market
16. UK Specialty Enzymes Market
17. Germany Specialty Enzymes Market
18. France Specialty Enzymes Market
19. Eastern Europe Specialty Enzymes Market
20. Russia Specialty Enzymes Market
21. North America Specialty Enzymes Market
22. USA Specialty Enzymes Market
23. South America Specialty Enzymes Market
24. Brazil Specialty Enzymes Market
25. Middle East Specialty Enzymes Market
26. Africa Specialty Enzymes Market
27. Specialty Enzymes Market Competitive Landscape And Company Profiles
31. Appendix
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AB Enzymes
- Amicogen inc.
- Aumgene Biosciences
- Biocatalysts Ltd.
- Codexis inc.
- Koninklijke DSM N.V.
Major players in the specialty enzymes market are BASF SE, Novozymes A/S, Roche Holding AG, Codexis Inc., Specialty Enzymes & Probiotics, Advanced Enzyme Technologies Ltd., BBI Solutions, E. I. du Pont de Nemours and Company, Sanofi and Amano Enzyme Inc.
The global specialty enzymes market is expected to grow from $5.21 billion in 2021 to $5.57 billion in 2022 at a compound annual growth rate (CAGR) of 7.1%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $7.35 billion in 2026 at a CAGR of 7.1%.
The specialty enzymes market consists of sales of specialty enzymes which are proteins acting as biocatalysts to accelerate the rate of reactions. The revenue generated by the market involves the sales of specialty enzymes that include carbohydrases, proteases, lipasesand lipases, among others in liquid or dry form, which are produced either from microorganisms, plants or animals. Specialty enzymes are primarily used in pharmaceutical, diagnostics, animal nutrition, food & beverage, research, and biotechnology.
The main types of specialty enzymes are carbohydrases, proteases, lipases, polymerases & nucleases, oxidase & hydratases, others. Any of a class of enzymes (such as amylase) that promotes carbohydrate breakdown or synthesis is referred to as a carbohydrase (such as a disaccharide). The different sources include microorganisms, animals, plants and is used in pharmaceutical, diagnostics, research and biotechnology, food and beverage, animal nutrition, others.
North America is the largest region in the viral specialty enzymes market in 2021. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Growing investment in biotechnology research & development is expected to boost market growth during the forecast period. Specialty enzymes are widely used in biotech research and development, particularly in molecular biology. The increasing investment and an increase in the number of companies conducting biotechnology research & development will in turn increase the number of biotech researches. For instance, according to the European House Ambrosetti, pharma R&D investments in Italy surged by 31% between 2013 and 2019, above the European average of 24%, and reaching €1.6 billion (US$1.94 billion) in 2019. According to the Assobiotec publication BioInItaly 2020, healthcare is involved in 49% of the over 700 biotech firms headquartered in Italy . There were 127 newer companies incorporated in just the first two months of 2019, which represents 3 new companies each new working day. Thus, the growing number of biotech research companies following increasing investments in biotech R&D is expected to boost the specialty enzymes market.
Ethical and societal issues are factors that will slow down the market growth during the forecast period. The clashing public opinions on these issues will determine the acceptability of new industrial biotechnology products. In 2019, a published article stated that there are five societal and ethical themes concerning industrial biotechnology namely sustainability, naturalness, risk management, innovation trajectories and economic justice. Many critics state the factor affecting economic justice is that the applications of industrial biotechnology lead to the concentration of knowledge and power in the hands of a few companies. Thus, societal and ethical issues are expected to impact market growth.
Technological advancements show opportunities for the production of enzyme products in a more efficient way. Challenges such as complexity in maintaining pH, operational high temperature of specialty enzymes and significant cost of maintenance of specialty enzyme products paves way for technological advancements. In 2019, an article published in Plant Biotechnology Journal stated the commercial launch of leaf pectinase powder developed using a new platform technology namely leaf-production platform. The leaf pectinase powder produced using leaf-production platform showed promising results like functionality in broad pH/temperature ranges as crude leaf extracts, leaf pectinase powder was stored up to 16 months at ambient temperature without loss of enzyme activity, unlike commercial enzyme products. This leaf-production platform is a novel technology for enzyme production with the elimination of fermentation, purification, concentration, formulation and cold chain processes.
In May 2021, BRAIN AG, a Germany-based industrial biotechnology company that identifies and develops innovative solutions and products for use in chemistry, cosmetics and food industries, acquired additional shares in Biocatalysts Ltd for $ 5.51 million (GBP 3.9 million). The acquisition further strengthens BRAIN’s BioIndustrial segment and widens commercial opportunities with Biocatalyst's portfolio and technology including access to BRAIN’s unique BioArchive and Biocatalyst’s MetXtra metagenomic library. Biocatalysts Ltd. is a UK-based manufacturer of specialty enzymes that focuses on the use of technology to develop novel specialty enzymes in a cost-effective manner.
The countries covered in the specialty enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The global specialty enzymes market is expected to grow from $5.21 billion in 2021 to $5.57 billion in 2022 at a compound annual growth rate (CAGR) of 7.1%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $7.35 billion in 2026 at a CAGR of 7.1%.
The specialty enzymes market consists of sales of specialty enzymes which are proteins acting as biocatalysts to accelerate the rate of reactions. The revenue generated by the market involves the sales of specialty enzymes that include carbohydrases, proteases, lipasesand lipases, among others in liquid or dry form, which are produced either from microorganisms, plants or animals. Specialty enzymes are primarily used in pharmaceutical, diagnostics, animal nutrition, food & beverage, research, and biotechnology.
The main types of specialty enzymes are carbohydrases, proteases, lipases, polymerases & nucleases, oxidase & hydratases, others. Any of a class of enzymes (such as amylase) that promotes carbohydrate breakdown or synthesis is referred to as a carbohydrase (such as a disaccharide). The different sources include microorganisms, animals, plants and is used in pharmaceutical, diagnostics, research and biotechnology, food and beverage, animal nutrition, others.
North America is the largest region in the viral specialty enzymes market in 2021. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Growing investment in biotechnology research & development is expected to boost market growth during the forecast period. Specialty enzymes are widely used in biotech research and development, particularly in molecular biology. The increasing investment and an increase in the number of companies conducting biotechnology research & development will in turn increase the number of biotech researches. For instance, according to the European House Ambrosetti, pharma R&D investments in Italy surged by 31% between 2013 and 2019, above the European average of 24%, and reaching €1.6 billion (US$1.94 billion) in 2019. According to the Assobiotec publication BioInItaly 2020, healthcare is involved in 49% of the over 700 biotech firms headquartered in Italy . There were 127 newer companies incorporated in just the first two months of 2019, which represents 3 new companies each new working day. Thus, the growing number of biotech research companies following increasing investments in biotech R&D is expected to boost the specialty enzymes market.
Ethical and societal issues are factors that will slow down the market growth during the forecast period. The clashing public opinions on these issues will determine the acceptability of new industrial biotechnology products. In 2019, a published article stated that there are five societal and ethical themes concerning industrial biotechnology namely sustainability, naturalness, risk management, innovation trajectories and economic justice. Many critics state the factor affecting economic justice is that the applications of industrial biotechnology lead to the concentration of knowledge and power in the hands of a few companies. Thus, societal and ethical issues are expected to impact market growth.
Technological advancements show opportunities for the production of enzyme products in a more efficient way. Challenges such as complexity in maintaining pH, operational high temperature of specialty enzymes and significant cost of maintenance of specialty enzyme products paves way for technological advancements. In 2019, an article published in Plant Biotechnology Journal stated the commercial launch of leaf pectinase powder developed using a new platform technology namely leaf-production platform. The leaf pectinase powder produced using leaf-production platform showed promising results like functionality in broad pH/temperature ranges as crude leaf extracts, leaf pectinase powder was stored up to 16 months at ambient temperature without loss of enzyme activity, unlike commercial enzyme products. This leaf-production platform is a novel technology for enzyme production with the elimination of fermentation, purification, concentration, formulation and cold chain processes.
In May 2021, BRAIN AG, a Germany-based industrial biotechnology company that identifies and develops innovative solutions and products for use in chemistry, cosmetics and food industries, acquired additional shares in Biocatalysts Ltd for $ 5.51 million (GBP 3.9 million). The acquisition further strengthens BRAIN’s BioIndustrial segment and widens commercial opportunities with Biocatalyst's portfolio and technology including access to BRAIN’s unique BioArchive and Biocatalyst’s MetXtra metagenomic library. Biocatalysts Ltd. is a UK-based manufacturer of specialty enzymes that focuses on the use of technology to develop novel specialty enzymes in a cost-effective manner.
The countries covered in the specialty enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- BASF SE
- Novozymes A/S
- Roche Holding AG
- Codexis inc.
- Specialty Enzymes & Probiotics
- Advanced Enzyme Technologies Ltd.
- BBI Solutions
- E. I. du Pont de Nemours and Company
- Sanofi
- Amano Enzyme inc.
- Nagase & Co. Ltd.
- Affymetrix inc.
- Biocatalysts Ltd.
- Life Technologies Corporation
- Amicogen inc.
- AB Enzymes
- Dyadic International inc.
- Chr. Hansen Holding A/S
- Merck KGaA
- Biovet Private Limited
- Antozyme Biotech
- Kerry inc.
- Thermo Fisher Scientific inc.
- Koninklijke DSM N.V.
- Aum Enzymes
- Ultra Bio-Logics inc.
- Aumgene Biosciences
- The Soufflet Group
- Shandong Longda Bio-Products Co. Ltd.
Note: Product cover images may vary from those shown
LOADING...